Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

New research finds hedge funds see institutional credibility is key for growth

Tuesday, September 10, 2013

Beverly Chandler, Opalesque London:

New global research undertaken by analyst firm Aite Group and SunGard finds that hedge funds see institutional credibility as a key element for profitability and achieving growth.

The research surveyed 40 senior executives and managers from Tier I and Tier II hedge funds in the U.S., Europe and Asia and found that nearly 80% of firms see their investment management infrastructure as critical to achieving more efficient operations. The survey finds: "The concept of institutional credibility is the idea of the ability of an investment firm to instil confidence to the outside world surrounding its operational stability and reliability."

Paul Compton, head of strategy for SunGard’s Asset Management business said: "The survey confirms the importance of what we are calling 'institutional credibility’ – a concept that will be immediately recognisable to anyone in the world of hedge funds. The fund-raising process now involves much more detailed operational due diligence than in the early days of the industry. To achieve institutional credibility, hedge funds today need to focus on ensuring they have an operating model that stands up under scrutiny from investors and regulators, that supports their business development and the search for alpha, and that enables them to control rising cost pressures."

Key findings fr......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its